Drugs Made In America Acquisition Corp Units
DMAAU
8 hedge funds and large institutions have $6.73M invested in Drugs Made In America Acquisition Corp Units in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
1.6% less ownership
Funds ownership: 4.83% → 3.24% (-1.6%)
11% less funds holding
Funds holding: 9 → 8 (-1)
34% less capital invested
Capital invested by funds: $10.2M → $6.73M (-$3.45M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kryger Capital
London,
United Kingdom
|
+$3.14M |
| 2 |
CS
Clear Street
New York
|
+$16.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
-$3.33M |
| 2 |
CCM
Context Capital Management
Lajolla,
California
|
-$2.58M |
| 3 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$591K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$21.6K |
DMAAU Hedge Fund Activity: Q3 2025 in Review
8 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition Corp Units (DMAAU) for Q3 2025, worth a combined $6.73M — down 34% from $10.2M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of DMAAU and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Kryger Capital, opening a new position worth an estimated $3.14M. The largest seller was Rivernorth Capital Management, cutting an estimated $3.33M.
- 8 institutional investors held Drugs Made In America Acquisition Corp Units (DMAAU) as of Q3 2025, down from 9 in Q2 2025.
- Funds reported $6.73M of Drugs Made In America Acquisition Corp Units stock for Q3 2025, down 34% quarter-over-quarter.
- 1 fund opened new Drugs Made In America Acquisition Corp Units positions in Q3 2025 and 2 closed out, a net change of -1 holder.
- The largest Drugs Made In America Acquisition Corp Units buyer in Q3 2025 was Kryger Capital, an estimated $3.14M added.
- The largest Drugs Made In America Acquisition Corp Units seller in Q3 2025 was Rivernorth Capital Management, an estimated $3.33M sold.
Based on aggregated 13F filings for Q3 2025.